Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Too little emphasis has been placed upon bleeding signs in children with idiopathic thrombocytopenic purpura (ITP). The frequency, location, and severity of clinical bleeding should dominate management considerations and the actual platelet count should be de-emphasized. With the notable exception of intracranial bleeding, virtually all prior literature reports describing case series or randomized trials of ITP have not addressed or even mentioned bleeding signs in study subjects. Future clinical investigations in childhood ITP should include a careful description of bleeding manifestations in the study populations and should assess outcome in terms of bleeding signs, quality of life, toxicity of therapy, cost, and, incidentally, the platelet count.

Original languageEnglish (US)
JournalJournal of Pediatric Hematology/Oncology
Volume25
Issue numberSUPPL. 1
DOIs
StatePublished - Dec 2003

Fingerprint

Idiopathic Thrombocytopenic Purpura
Hemorrhage
Platelet Count
Quality of Life
Costs and Cost Analysis
Population

Keywords

  • Bleeding
  • Idiopathic
  • ITP
  • Platelet
  • Thrombocytopenia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura. / Buchanan, George R.

In: Journal of Pediatric Hematology/Oncology, Vol. 25, No. SUPPL. 1, 12.2003.

Research output: Contribution to journalArticle

@article{7c14c58f843148bf822a2c7b59ec6141,
title = "Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura",
abstract = "Too little emphasis has been placed upon bleeding signs in children with idiopathic thrombocytopenic purpura (ITP). The frequency, location, and severity of clinical bleeding should dominate management considerations and the actual platelet count should be de-emphasized. With the notable exception of intracranial bleeding, virtually all prior literature reports describing case series or randomized trials of ITP have not addressed or even mentioned bleeding signs in study subjects. Future clinical investigations in childhood ITP should include a careful description of bleeding manifestations in the study populations and should assess outcome in terms of bleeding signs, quality of life, toxicity of therapy, cost, and, incidentally, the platelet count.",
keywords = "Bleeding, Idiopathic, ITP, Platelet, Thrombocytopenia",
author = "Buchanan, {George R.}",
year = "2003",
month = "12",
doi = "10.1097/00043426-200312001-00010",
language = "English (US)",
volume = "25",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Bleeding Signs in Children with Idiopathic Thrombocytopenic Purpura

AU - Buchanan, George R.

PY - 2003/12

Y1 - 2003/12

N2 - Too little emphasis has been placed upon bleeding signs in children with idiopathic thrombocytopenic purpura (ITP). The frequency, location, and severity of clinical bleeding should dominate management considerations and the actual platelet count should be de-emphasized. With the notable exception of intracranial bleeding, virtually all prior literature reports describing case series or randomized trials of ITP have not addressed or even mentioned bleeding signs in study subjects. Future clinical investigations in childhood ITP should include a careful description of bleeding manifestations in the study populations and should assess outcome in terms of bleeding signs, quality of life, toxicity of therapy, cost, and, incidentally, the platelet count.

AB - Too little emphasis has been placed upon bleeding signs in children with idiopathic thrombocytopenic purpura (ITP). The frequency, location, and severity of clinical bleeding should dominate management considerations and the actual platelet count should be de-emphasized. With the notable exception of intracranial bleeding, virtually all prior literature reports describing case series or randomized trials of ITP have not addressed or even mentioned bleeding signs in study subjects. Future clinical investigations in childhood ITP should include a careful description of bleeding manifestations in the study populations and should assess outcome in terms of bleeding signs, quality of life, toxicity of therapy, cost, and, incidentally, the platelet count.

KW - Bleeding

KW - Idiopathic

KW - ITP

KW - Platelet

KW - Thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=0344736748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344736748&partnerID=8YFLogxK

U2 - 10.1097/00043426-200312001-00010

DO - 10.1097/00043426-200312001-00010

M3 - Article

C2 - 14668639

AN - SCOPUS:0344736748

VL - 25

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - SUPPL. 1

ER -